Galle PR - Search Results

1

All-trans retinoic acid for treatment of chronic hepatitis C.

Böcher WO, Wallasch C, Höhler T, Galle PR. Böcher WO, et al. Among authors: galle pr. Liver Int. 2008 Mar;28(3):347-54. doi: 10.1111/j.1478-3231.2007.01666.x. Liver Int. 2008. PMID: 18290777 Clinical Trial.

2

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.

Rahman F, Dahmen A, Herzog-Hauff S, Böcher WO, Galle PR, Löhr HF. Rahman F, et al. Among authors: galle pr. Hepatology. 2000 Feb;31(2):521-7. doi: 10.1002/hep.510310237. Hepatology. 2000. PMID: 10655280

3

How long to treat chronic hepatitis B virus infection with lamivudine?

Löhr HF, Schlaak JF, Lohse AW, Böcher WO, Kanzler S, Ibe M, Galle PR. Löhr HF, et al. Among authors: galle pr. J Hepatol. 2000 Aug;33(2):343. doi: 10.1016/s0168-8278(00)80381-5. J Hepatol. 2000. PMID: 10952257 No abstract available.

4

Heterozygosity for the hemochromatosis gene in liver diseases--prevalence and effects on liver histology.

Höhler T, Leininger S, Köhler HH, Schirmacher P, Galle PR. Höhler T, et al. Among authors: galle pr. Liver. 2000 Dec;20(6):482-6. doi: 10.1034/j.1600-0676.2000.020006482.x. Liver. 2000. PMID: 11169063

5

IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients.

Kaluza W, Leirisalo-Repo M, Märker-Hermann E, Westman P, Reuss E, Hug R, Mastrovic K, Stradmann-Bellinghausen B, Granfors K, Galle PR, Höhler T. Kaluza W, et al. Among authors: galle pr. Arthritis Rheum. 2001 May;44(5):1209-14. doi: 10.1002/1529-0131(200105)44:5<1209::AID-ANR205>3.0.CO;2-S. Arthritis Rheum. 2001. PMID: 11352256 Free article.

6

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.

Hempel G, Galle PR, Löhr HF. Hempel G, et al. Among authors: galle pr. J Med Virol. 2001 Jul;64(3):340-9. doi: 10.1002/jmv.1056. J Med Virol. 2001. PMID: 11424124

7

Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.

Böcher WO, Dekel B, Schwerin W, Geissler M, Hoffmann S, Rohwer A, Arditti F, Cooper A, Bernhard H, Berrebi A, Rose-John S, Shaul Y, Galle PR, Löhr HF, Reisner Y. Böcher WO, et al. Among authors: galle pr. Eur J Immunol. 2001 Jul;31(7):2071-9. doi: 10.1002/1521-4141(200107)31:7<2071::aid-immu2071>3.0.co;2-d. Eur J Immunol. 2001. PMID: 11449360 Free article.

8

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.

Dahmen A, Herzog-Hauff S, Böcher WO, Galle PR, Löhr HF. Dahmen A, et al. Among authors: galle pr. J Med Virol. 2002 Apr;66(4):452-60. doi: 10.1002/jmv.2165. J Med Virol. 2002. PMID: 11857521 Clinical Trial.

9

Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.

Pingel S, Weyer S, Galle PR, Löhr HF. Pingel S, et al. Among authors: galle pr. J Med Virol. 2002 Apr;66(4):472-80. doi: 10.1002/jmv.2168. J Med Virol. 2002. PMID: 11857524

10

[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].

Böcher W, Galle PR, Märker-Hermann E. Böcher W, et al. Among authors: galle pr. Dtsch Med Wochenschr. 2002 Apr 5;127(14):735-8. doi: 10.1055/s-2002-24401. Dtsch Med Wochenschr. 2002. PMID: 11935470 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

820 results

Search Page